1-182900135-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_030933.4(SHCBP1L):c.1810G>A(p.Val604Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,612,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_030933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHCBP1L | NM_030933.4 | c.1810G>A | p.Val604Ile | missense_variant | 10/10 | ENST00000367547.8 | NP_112195.2 | |
SHCBP1L | NM_001345928.2 | c.1453G>A | p.Val485Ile | missense_variant | 11/11 | NP_001332857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHCBP1L | ENST00000367547.8 | c.1810G>A | p.Val604Ile | missense_variant | 10/10 | 1 | NM_030933.4 | ENSP00000356518 | P1 | |
SHCBP1L | ENST00000483655.5 | n.1753G>A | non_coding_transcript_exon_variant | 11/11 | 1 | |||||
SHCBP1L | ENST00000488956.5 | n.2270G>A | non_coding_transcript_exon_variant | 9/9 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000403 AC: 10AN: 248276Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134248
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460010Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 726262
GnomAD4 genome AF: 0.000243 AC: 37AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74228
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at